A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT02815891 · COMPLETED

Trial details

NCT number: NCT02815891
Sponsor: Target PharmaSolutions, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Nonalcoholic Fatty Liver Nonalcoholic Steatohepatitis

Start date: 2016-07-01
Primary completion: 2026-05-01
Enrollment: 7330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.